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Abstract
The current study aims to examine the effectiveness of mindfulness meditation via telehealth as
part of routine care in an outpatient substance use treatment program in Jakarta, Indonesia. The
randomized controlled study design was performed to find the difference between the mean
score of the Mindfulness Attention and Awareness Scale (MAAS) and the Aggregated Drug
Craving Scale (ADCS) level before and after the intervention for the treatment group (n=15) and
the control group (n=15). The two 2-way ANOVA (groups x times) was conducted to find the
difference in ADCS and MAAS scores between the treatment group who received the Treatment
as Usual (TAU) plus the additional four weekly telehealth mindfulness meditation sessions and
the control group who received the TAU only. This study found that there was no significant
difference in the average score of the MAAS (F (1, 56) = .147, p = .702, ηp2 = .003) and the
ADCS (F (1, 56) = .358, p = .552, ηp2 = .006) for any interaction of groups, both treatment and
control groups. There was also no significant difference in the average score of the MAAS score
(F (1, 56) = .077, p = .783, ηp2 = .001) and the ADCS score (F (1, 56) = 1.88, p = .175, ηp2 =
.033) for any type of intervention times, both at pretest and posttest. Hence, this study concluded
that the TAU with added telehealth mindfulness meditation is not more effective than the TAUonly in reducing substance use craving.
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Chapter I: Introduction and Statement of the Problem
The COVID-19 Pandemic has brought major challenges to many aspects of human life.
The World Health Organization (WHO) recommends social distancing and social restriction to
prevent the spread of the COVID-19 virus that has been in existence since May 2020. Many
countries have been using strategies to lower the cases through vaccination, mandatory face
mask usage in public facilities, avoiding physical touch, flight restrictions to countries with a
high number of cases, enforcing online learning, work-from-home policies, etc. People are
required to avoid crowds, and many prefer staying at home, especially during the first virus
outbreak in 2020.
There were a lot of uncertainties, especially at the beginning of the Pandemic, the fear of
safety and concerns of getting infected, the closure of public facilities, the overwhelming
information from media, quarantine, and job insecurity, all of which triggered the mental health
problems. Those situations may affect individuals' mental and physical health. Studies from
Benke et al. (2020) and Lahiri et al. (2021) identify social distancing as a major factor that can
increase anxiety, depression, and distress. The hardship of making a person-to-person connection
can result in a loss of a sense of belonging (Sikali, 2020) and several negative mental health
implications (Dezecache et al., 2020). Another study by Xiong et al. (2020) also identified the
impact of the surge of COVID-19 cases on greater issues in society such as employment losses,
social isolation, financial burden, and exacerbating mental health symptoms including
depression, fear, and anxiety.
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The social changes caused by the Pandemic certainly worsened some at-risk populations
during this period. Emerging evidence has identified several populations at risk for high levels of
psychological distress during the Pandemic, including women, individuals living in low-income
homes, people with disabilities, those with prior histories of mental illness, and people with SUD
(Alonzi et al., 2020; Cevik & Ungan, 2021; Rodríguez-Rey et al., 2020). During the Pandemic,
there was an increasing number of substance misuse as self-medication and coping mechanisms
(Brooks et al., 2020; Slaven et al., 2017). Accordingly, people with SUD are at greater risk of
recurrent hospitalization due to elevated SUD-related preexisting health conditions such as
physical health problems (Jemberie et al., 2020).
The impact of COVID-19 is also unprecedented and devastating to the treatment facilities
for people with SUD. Quarantine, physical distancing, and temporary closure of public facilities
that mitigate the consequences of the COVID-19 Pandemic have undermined SUD clients'
access to treatment and recovery services, especially during the onset period of the Pandemic
(Lin et al., 2022). Another study from Basu (2020) mentioned that the temporary closure of
healthcare facilities during the COVID-19 has deprived access to patients with regular
medication, including people with substance use disorders.
The restriction of person-to-person appointments impacts the delivery strategies of the
treatment program. It requires hospitals, clinics, or other healthcare facilities to engage in more
new and non-traditional forms of treatment and prevention strategies. Many health care facilities,
mental health treatment facilities, and other health services could not serve walk-in clients as
they were concerned about getting infected. The reduced transportation services during
pandemics were also a barrier for clients to come to the treatment site. Thus, most treatment
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facilities, including substance use treatment, transitioned to telehealth services options that will
likely continue well past the Pandemic.
Based on the report from United Nations Office on Drugs and Crime (2021) on World
Drug Report, the number of drug users is expected to increase by 11% globally by 2030. About
275 million people worldwide used drugs in 2020, up from 226 million in 2010, a 22% increase.
Accordingly, many countries noted a rise in marijuana use and the use of non-medical
pharmaceutical drugs such as benzodiazepines due to this stressful situation. Abramson (2021)
stated that based on data from the Centers for Disease Control and Prevention, as of June 2020,
13% of Americans reported starting or increasing substance use as a way of coping with stress or
emotions related to COVID-19. Overdoses have also spiked since the onset of the pandemic.
Accordingly, the Overdose Detection Mapping Application Program (ODMAP), an application
system to track and analyze overdoses in the United States, shows that the early months of the
pandemic brought an 18% increase nationwide in overdose. The report from American Medical
Association (2020) also provides the spiked numbers of drug trend in 2020 more than 40 states
have increasing opioid-related mortality along with ongoing concerns for those with substance
use disorders.
Compared to the situation in Indonesia, there is a similarity in the increasing number of
people who use drugs and alcohol during the Pandemic. The drug trend during social distancing
in 2021 tended to increase compared to 2019. The rising number of substance users during the
Pandemic was followed by major loss events such as the death of family members or friends,
financial concerns, health issues, etc. On the article by Marhaenjati & Santosa (2021), the survey
from National Narcotics Board Republic of Indonesia showed that the prevalence of people who
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use drugs increased from 3.4 million in 2019 to 3.6 million in 2021. Based on the same article, it
also mentioned that the National Narcotics Board Republic of Indonesia also released the
number of people who have been exposed to illicit drugs in Indonesia has increased from 4.5
million in 2019 to 4.8 million in 2021.
Thus, considering these numbers, continuity of treatment and care during the
Pandemic was essential to address emerging and ongoing SUD problems; as such, the onset of
the COVID-19 Pandemic brought about tremendous growth in the use of telehealth across a
range of healthcare providers and medical conditions, including substance use treatment
facilities. Many treatment facilities in Indonesia, including outpatient programs, no longer
provide an in-person program as the number of COVID-19 cases increases. Outpatient treatment
is now preferred to provide individual and group therapy through an online platform and requires
less on-site walk-in treatment.
In the middle of the rising use of telehealth services, treatment facilities may find it
challenging to maintain clients' sobriety through virtual access. Some challenges include
difficulties in engagement and rapport and the loss of visual contact to observe more clients'
facial expressions and craving behavior (Searby & Burr, 2021). In contrast, in-person meetings
allow facilitators or counselors to monitor the craving behavior and Post-Acute-Withdrawal
Symptoms (PAWS) more easily than through a screen. Craving, which is typically characterized
as an overwhelming or compelling desire to consume drugs or alcohol, does not always precede
consumption, nor does it always lead to smoking, drinking, or drug usage (Tiffany, 1990).
Nonetheless, the craving concept has been central to discussions of addiction, largely because it
is assumed to be the main trigger factor for relapses in drugs and alcohol (de Bruijn et al., 2005).
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Furthermore, craving can be a predictive factor in determining treatment success (Panlilio
et al., 2019). It is essential for treatment facilities to identify the craving signs. Research shows a
significant relationship between emotional dysregulation, negative affect, and depression with
craving behavior (Marino et al., 2019). Consequently, training to teach people with SUDs
emotional regulation skills seems to be effective in preventing addiction vulnerability and
reducing craving, relapse, and associated emotional problems. Mindfulness meditation practice is
considered a way to manage emotional regulation that underlies addictive behaviors, cravings,
and relapse. It is regarded as a promising treatment for creating awareness and leading people to
accept thoughts, feelings, and emotions through mindfulness practice and as a coping strategy in
the face of high-risk situations. The term of "mindfulness" refers to maintaining a moment-bymoment awareness of one's thoughts, feelings, bodily sensations, and surrounding environment.
According to Kabat-Zinn, "mindfulness emerges through paying attention on purpose, in the
present moment, and nonjudgmentally to the unfolding of experience moment by moment"
(Kabat-Zinn, 2003, p.145).
Additionally, mindfulness enhances cognitive awareness and helps monitor automatic
cognitive and emotional processes (Garland et al., 2009). Mindfulness also increases acceptance
of thoughts and feelings without judging them and focusing on what is occurring in the present
moment instead of rehashing the past or planning the future (Kabat-Zinn, 2003). Hence,
considering the advantage of enhancing awareness in identifying situations that are related to
craving thoughts, the present study evaluated the use of mindfulness meditation via telehealth
platforms in the substance use outpatient treatment facility.
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The Operational Definitions
The Effectiveness
The effectiveness was determined by the participants showing statistically significantly
less duration and frequency of craving alcohol and drugs after participating in the four-weekly
mindfulness meditation program.
Mindfulness Meditation
Mindfulness meditation is determined by practicing weekly meditation through guided
meditation video as an additional treatment during the outpatient treatment program.
Outpatient Program
Outpatient program defined by an intensive program for substance use disorders that
provide individual and group meetings and for clients that have been diagnosed with substance
use disorders through comprehensive assessment.
Craving
This study determines substance use craving by using the Aggregated Drug Craving
Scale (ADCS).
Substance Use Disorders
Substance use disorders are determined by individuals that are admitted to the substance
use program through comprehensive assessment.
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Chapter II: Literature Review
This section covers a range of literature that is intended to put the mindfulness technique
in context with substance use treatment. This section also looks at a study which utilized a
mindfulness meditation approach via telehealth as its primary technique to reduce the substance
craving. Prior to this, this chapter begins by examining the definition and history of the
mindfulness study and how it has been used successfully in other fields of mental health.
The Definition and History of Mindfulness Study
The mindfulness method has a history of use in various fields. It is well-known that
psychological well-being has been attributed to the definition of mindfulness theoretically and
empirically. The awareness and nonjudgmental acceptance elements of one's present moments
are the core elements of mindfulness. Some studies found that achieving Mindfulness is a
potentially effective treatment against psychological distress such as anxiety, anger, and fear,
which involves the maladaptive tendencies to suppress feelings and thoughts (Kabat-Zinn,
1990).
Most researchers in different studies describe Mindfulness in the same way. One of the
common mindfulness definitions is by Baer (2003), which defines it as "the nonjudgmental
observation of the ongoing stream of internal and external stimuli as they arise" (p. 125). Even
though some researchers work almost exclusively on the attentional aspects of the mindfulness
(Brown & Ryan, 2003), many researchers and practitioners adopt the model from Bishop
(2002) in general, which explained that mindfulness encompasses two components: selfregulation of attention and adoption of a particular orientation towards one's experiences.
Mindfulness technique requires both the ability to anchor individual's attention on what is
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occurring and also able to switch the attention intentionally from one moment of the experience
to another.
Mindfulness meditation helps increase the attention to bodily sensation nonjudgmentally,
which in turn changes the way individual views moments to moments experiences (Gunaratana,
2011). It allows individuals to change the way their automatic reactions into non-judgment
responses. Kabat-Zinn (1990) stated the essence of mindfulness is when we raise awareness and
increase our attention to everything we do daily. The behavior of raising attention becomes a
coping mechanism to address an individual's irrational thoughts and beliefs (Gunaratana, 2011).
Kabat-Zinn (1994) also emphasizes the importance of paying attention without holding onto
personal judgment that will encourage a sense of consciousness.
Most researchers in different studies describe Mindfulness in the same way. One of the
common mindfulness definitions is by Baer (2003), which defines it as "the nonjudgmental
observation of the ongoing stream of internal and external stimuli as they arise" (p. 125). Even
though some researchers work almost exclusively on the attentional aspects of the mindfulness
(Brown & Ryan, 2003), many researchers and practitioners adopt the model from Bishop (2002)
in general, which explained that mindfulness encompasses two components: self-regulation of
attention and adoption of a particular orientation towards one's experiences. Mindfulness
technique requires both the ability to anchor individual's attention on what is occurring and also
able to switch the attention intentionally from one moment of the experience to another.
Interventions based on the dynamic interactions of mind and body, especially meditation
and mindfulness, are the ones that originated from Eastern therapies and have been frequently
practiced as psychological therapeutic programs in recent years (Kabat-Zinn, 2003). It is
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common to utilize the term of mindfulness to describe several terms such as a psychological trait,
a practice of cultivating awareness (e.g., mindfulness meditation), state of awareness, or a
psychological and mental process (Germer et al., 2005). One of the most commonly quoted
explanations of mindfulness is the awareness that emerges through “paying attention in a
particular way: on purpose, in the present moment, and nonjudgmentally” (Kabat-Zinn, 1994, p.
4). There is similar definition of mindfulness that provided by most other researchers. One of
common description from Baer (2003), defines mindfulness as “the nonjudgmental observation
of the ongoing stream of internal and external stimuli as they arise” (p. 125).
The meaning of "acceptance" in the context of mindfulness is not similar to passive
behavior or resignation (Cardaciotto et al., 2008). Instead, the term of acceptance in this context
refers to the ability to experience with full awareness and expand cognitive flexibility without
resorting to the extreme judgment of the experience. Current conceptualizations of mindfulness
in clinical psychology point to two primary, essential elements of mindfulness: Awareness of
one's moment-to-moment experience nonjudgmentally and acceptance.
Studies of Mindfulness Practices
As mindfulness gained increasing popularity, more studies were conducted to investigate
its effectiveness in promoting clients' well-being. The following studies illustrated the
information about the benefits of mindfulness meditation in psychological and spiritual wellbeing. In a quasi-experimental pilot study, Bryan et al. (2021) examined the ten-week of yoga
and mindfulness meditation used to improve the spiritual well-being of cancer survivors. The
results showed that there was a significant improvement in the spiritual well-being of cancer
survivors as a vital role in health care approaches. Accordingly, a study by Fazia et al. (2021)
demonstrated the benefits of mindfulness practices in increasing the well-being of a working
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population. Over 59 participants who were involved in the study received 12 weeks of
mindfulness sessions, which showed lower stress and higher self-compassion that promoting
well-being.
Moreover, a study by Whitton (2019) examined the Mindfulness-Based Intervention that
adapted from Mindfulness-Based Cognitive Therapy and Mindfulness-Based Stress Reduction to
improve the psychological well-being of patients in a mental health hospital. Unfortunately, the
study did not provide the information on mental health diagnosis of the participants, however,
after eight-week intervention, the results showed improvement in participants’ well-being score.
Accordingly, a more specific quasi-experimental study from Yela et al. (2022) demonstrated the
benefit of mindfulness training in increasing self-compassion, enhancing mental health, and
improving well-being. The results for over 50 participants that involved in Spain and Portugal
showed that mindfulness training can increase self-compassion and significantly correlated with
the decreasing anxiety, depression, and psychological well-being.
Mindfulness has been found to be more effective if it is combined with other behavioral
treatment approaches and to increase functional recovery in various clients. When combining
mindfulness with Cognitive Behavioral Therapy (CBT), mindfulness showed a positive effect on
therapy process (Bowen et al., 2014). Studies below explained the promising results when
combining mindfulness in a mental health recovery. Study from Özdemir & Kavak Budak (2022)
showed Mindfulness-Based Stress Reduction (MBSR) training can increase the level of hope and
psychological well-being for patients with schizophrenia. The study compared control group who
received the psychoeducation only treatment and treatment group who received psychoeducation
plus MBSR in eight weeks of program. The results showed that the psychoeducation plus
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MBSR treatment gave more effective results in increasing the well-being and hope of patients to
support their recovery. Along the same lines, randomized controlled trial conducted by Schuling
et al. (2020) studied the combination of Mindfulness-Based Cognitive Therapy (MBCT) and
medical and psychological treatments for clients with depression. The results on 61 participants
showed significant reducing depressive symptoms for clients who received the medical and
psychological treatment combined with MBCT.
Previously Attempted Mindfulness Meditation in Substance Use Treatment
In an effort to minimize relapse and improve client outcomes, SUD treatment programs
have begun to introduce complementary and alternative medicine practices such as yoga and
mindfulness. Mindfulness-based intervention also shows promising results in the substance use
treatment. Studies below illustrated the use of mindfulness intervention in substance use
treatment facilities. The findings from a study conducted by Alizadehgoradel et al. (2019)
suggests that Mindfulness-Based Substance Abuse Treatment (MBSAT) successfully improved
response inhibition, risky decision-making, working memory, and cognitive flexibility in
adolescence. More studies that examined the Mindfulness-Based Relapse Prevention (MBRP)
from Zullig et al. (2021) to examine the use of MBRP for clients who received the medication
for Opioid Use Disorder. The results suggested that MBRP can be implemented as an outpatient
therapy for individuals with Opioid Use disorder who take the medication as it showed
significant decrease in craving and relapse after receiving the treatment.
In order to examine the effect of mindfulness, Jain et al. (2007) mentioned in their study
that the mechanisms that underly mindfulness training can result in the flexible cognitive style in
problem-solving. The judgment-free attitude along with acceptance can reduce anxiety and
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prevent repetitive thoughts such as rumination and worry resulting in emotional regulation. The
working of mindfulness in reducing craving and preventing relapse can be described in three
steps. Firstly, it is started by increasing awareness in identifying the present moment. Then, a
person can learn how to recognize some alternatives of choices in deciding, and to coordinate the
stressors and the emotions instead of reacting automatically to negative thoughts. Second, the
individual is enabled to overcome the fear or the pressure and say "no" to himself. This makes
the individual reach equilibrium and increases his self-confidence and assertiveness. Third, being
in the present moment with others leads to paying more attention to the support system such as
relationship and be in the treatment, and consequently continuation of the sobriety.
Mindfulness and Substance Use Craving
Evidence suggests that people with substance use disorders struggle to maintain their
sobriety due to relapse (Brandon et. al, 2007). This means that for some people, relapse, or a
return to drug use after an attempt to stop, may occur as a part of the process. The most
influential social-cognitive behavioral model of relapse proposed by Marlatt has emerged from
the recognition that relapse is the result of a series of maladaptive responses to internal or
external stressors. Like most other models, this one also proposes that individual experiences a
sense of perceived control while maintaining abstinence. Even though newer treatments are
designed to help with relapse prevention, the number of relapses considered is still high. The
relapsing and craving nature of substance addiction has made it clear that relapse prevention is
an essential treatment component for long-term sobriety, emphasizing on the attention that
propose to address this need.
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Craving is the desire to use substances based on personal experience. It creates thoughts
that make it difficult to focus on anything other than the substance (Bowen et al., 2014).
According to study from Tiffany (1990), most substance use craving among dependent users
occurs without conscious thought and thus bypasses momentary craving urges. In this model,
momentary increases in craving are conscious cues that indicate that substance use is currently
not available, for examples at office, taking care of children, trying to quit). An individual
experiences increasing momentary cravings is then faced with a decision as to whether to engage
in drug-seeking behavior, such as contacting dealers or meeting people who have the access to
illicit drugs, or engaging in inhibitory control, such as inhibiting prepotent thoughts, feelings,
and behaviors in order to be in line with treatment goals.
Studies from Garrison et al. (2015) showed that mindfulness exercises reduced the
craving of smoking. The practicing of mindfulness also can decrease the methamphetamine
dependent craving on males (Shareh et al., 2018). Other results to prove the use of Mindfulness
in reducing Substance Use craving from Temme and Wang (2018) that examined the 51
participants using self-reported Assessment of Warning Signs of Relapse Scale (AWARE), and
the Five Facet Mindfulness Questionnaire (FFMQ). The study demonstrated that the responses of
awareness and nonjudgment were related to ability to identify the warning signs of relapse.
Further, observing and nonjudgment abilities were associated with changes in negative mood
that could influence to the relapse and craving thoughts. Hence, it explained how the awareness
component of mindfulness state can be associated to external behavior of substance use.
Along with the development of combining mindfulness into therapeutic treatment, there
has been much theoretical and empirical work illustrating the impact of mindfulness on reducing
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the symptoms of lapse/relapse in substance use. Treloar et al. (2010) stated that if addiction
treatments are complemented with mindfulness, they might successfully influence substance
users’ judgement and aversion that may lead to craving. Individuals with SUDs can recognize
the early warning signs of craving or relapse by practicing the mechanism of mindfulness. In one
randomized trial study by Witkiewitz and Bowen (2010) concluded that practicing meditation
contributes a significant factor for people with substance use disorders to stay abstinent. Over
260 participants in the study were divided into two groups in treatment and control group. The
mindfulness training completed by the treatment group for eight 2-hour session weekly. It
revealed that mindfulness training might help clients with SUDs by attenuating the relation
between negative cognitive, emotional states and subjective experiences of craving. Along with
the studies, Abed & Ansari Shahidi (2019) examined the use of Mindfulness-Based Relapse
Prevention for clients who were receiving methadone therapy. Over the 55 Iranian adult males
that involved in the study (treatment group n=26) obtained lower lapse percentage after received
the mindfulness treatment.
The Use of Telehealth Platform in Treatment Facilities
Those studies above have examined the application of mindfulness in substance use
treatment facilities delivered in person. However, limited research has been found to identify
how mindfulness meditation reduces craving via online platforms or telehealth. Some robust
evidence demonstrates that telehealth is at least as effective as in‐person care for several
behavioral health conditions—particularly for depression and anxiety disorders. Some research
also shows that patients with behavioral health conditions are generally satisfied with telehealth,
both in terms of the patient's clinical experience and benefits of improved access to and
convenience of care.
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Lin et al. (2022) studied telehealth or telemedicine as the most substantial change that the
COVID-19 Pandemic posed in clinical services. Prior studies of patient perceptions of telehealth,
specifically for SUD care, have shown superior levels of patient satisfaction with telehealth
treatment comparable to in‐person therapy. However, the existing literature examining SUD care
via telehealth is limited to the client's satisfaction, not the programs' effectiveness. Moreover,
most studies applied mindfulness meditation in in-person treatment settings. Only a few studies
have determined the effectiveness of mindfulness meditation through online platforms.
Telehealth, nowadays, has become a preferred treatment delivery method including in
substance use treatment facilities. Therefore, the present study addresses the limitations in the
existing literature by examining the substance use craving and mindfulness scale across, before,
and after the intervention. This study aims to investigate the use of telehealth mindfulness
meditation as an additional treatment in the outpatient treatment facility in Jakarta, Indonesia.
Treatment group and control group participants received treatment as usual (TAU), but only
participants in the treatment group received the mindfulness meditation treatment via telehealth
in an outpatient SUD treatment program as part of routine care.
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Chapter III: Methodology
Research Design
This study examined the use of telehealth mindfulness meditation with randomized
controlled trial design in an outpatient treatment facility in Jakarta, Indonesia. Thirty participants
attended outpatient treatment as their usual program that involves comprehensive assessments,
eight individual treatment sessions, two group sessions and psychoeducation sessions. Fifteen
participants in the treatment group received additional four-weekly telehealth mindfulness
meditation sessions. Finally, data of 30 participants was analyzed with the SPSS 26 version
software.
Participants
The study consisted of 30 participants ages 18 to 60 years old who were diagnosed with
substance use disorders. Thirty participants were divided into two groups 15 participants were in
the control group and 15 participants were in the experimental group. Both groups received
outpatient program treatment as usual, such as individual and group therapy, but only the
experiment group received mindfulness meditation sessions.
The research inclusion criteria comprised the following:
1.

Age between 18 and 60 years old

2.

Diagnosed with substance use dependence through comprehensive assessment based on the
Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5).
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Table 1
The Intervention of the Study
Intervention
Pre-Intervention
Pre-Test in Mindfulness
Pre-Test in Substance Use
Craving
Intervention
8 sessions of individual and
group counseling
4 weekly sessions of the
telehealth mindfulness
meditation
Post treatment
Post-test in mindfulness scale
Post-test in craving scale

Control Group

Groups
Treatment Group

Yes
Yes

Yes
Yes

Yes

Yes

No

Yes

Yes
Yes

Yes
Yes

Setting
The study was conducted in an outpatient substance abuse treatment facility in Jakarta,
Indonesia. The facility program consisted of individual and group sessions. All clients were
assigned to a fixed counselor who led the entirety of individual and group sessions. Clients and
counselors met twice a week, however, due to the COVID-19 pandemic restriction, the facility
delivered the treatment program via Zoom and WhatsApp video call platforms. In this study,
only participants in the treatment group received four weekly mindfulness meditation sessions as
an additional treatment of the treatment-as-usual (TAU). The mindfulness meditation session
was conducted via Zoom for 15 minutes once a week before the participants had the counseling
sessions with their assigned counselors.
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Research Questions
This study examines the effectiveness of mindfulness meditation via telehealth in
reducing substance use craving. Research questions include:
1. Is the TAU with added telehealth mindfulness meditation more effective than the TAU in
reducing substance use craving?
2. What is the magnitude of the effect of mindfulness meditation on substance use craving?
Measures
Participants completed the Mindfulness Attention Awareness Scale (MAAS) and
Aggregated Drug Craving Scale (ADCS) scale before and after the treatment.
The Mindful Attention Awareness Scale (MAAS)
The MAAS is a 15-item scale self-report inventory that is designed to assess a core
characteristic of Mindfulness, focused attention, and awareness. According to Brown and Ryan
(2003), a key component of Mindfulness is an open, focused, intentional state of attention and
awareness that allows one to experience the present more deeply. Utilizing several different
populations and methods, Brown and Ryan found that the MAAS had a unidimensional factor
structure with very good psychometric properties. They also reported strong evidence of
convergent, discriminant, criterion-related, and incremental validity. A comprehensive review of
the mindfulness measurement literature (Park et al., 2013) concluded that, since its introduction
in 2003, the MAAS has been the most frequently used measure of Mindfulness and has
consistently demonstrated a unidimensional factor structure with strong internal consistency and
test-retest reliability. The MAAS was also found to be significantly correlated with other
mindfulness measures at low to moderate levels (r = 0.14–0.51).
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This scale has been adapted into the Indonesian language by Yusainy (2013) with MAAS
reliability for the sample of students in Indonesia at α = 0.770 and α= 0.810 (Yusainy et al.,
2018) and for the community sample at α= 0.880 (Yusainy & Lawrence, 2014). Participants were
asked to rate their experiences on a 6-point Likert scale ranging from 1 = “always” to 6 =
“never” (1 = “always”; 2 = “often”; 3 = “somewhat often”; 4 = “rarely”; 5 = “almost never”; 6 =
“never”). Mindfulness scores were obtained by adding a total of 15 items on the MAAS scale.
The higher the total score means the higher the individual’s level of mindfulness.
The Aggregated Drug Craving Scale (ADCS)
The ADCS is the adapted test from Penn Alcohol Craving Scale (PACS) to assess general
psychoactive substance (i.e., alcohol and drug) craving rather than alcohol craving. The scale
includes quantitatively defined questions on frequency, intensity, and duration of thoughts about
alcohol and drugs, ability to resist drug or alcohol use if available, and overall rating of craving
in the past week. Costello et al. (2020) have tested the validity and reliability of the adaptation of
PACS into ADCS in clients in a substance use treatment facility, and it showed statistically
significant concurrent validity in substance use and severity measurement. The study also found
that the ADCS had high reliability by assessing total craving scales between the two-time points
using Pearson's zero ordered correlation and the interclass correlation coefficient (ICC) (α=0.82,
p<0.001, ICC=0.82).
After receiving permission to adapt the ADCS into the Indonesian language through
emails, I followed standard translation procedures to translate the ADCS from the original
English version to the Indonesian language. I am qualified to do this as I am fluent in both
English and Indonesian, grew up in an Indonesian-speaking household, and have experience
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living and going to university in an English-speaking country for over a year. I also have taken a
graduate-level course in assessment and therefore understand the importance of item content to
the overall assessment validity and reliability. Once an Indonesian language version of the
ADCS was obtained, another bilingual translator conducted a back-translation, translating the
Indonesian version of the ADCS back into English. The other translator was able to do the back
translation due to the qualification, such as actively speaking Indonesia as a native language and
English as a secondary language, having the experience of living in an English-speaking country
for over one year and having completed graduate school in the psychology field. Back translation
of an assessment is used to determine if the translation of the instrument led to any substantial
changes in item content. Once a back-translated version of the ADCS was obtained, both
translators sat down with all three versions of the ADCS: original English, Indonesian
translation, and English version back-translated from Indonesian. The translators discussed item
content for each item and agreed upon a final Indonesian language version of the ADCS.
Procedures
Preparation and Pre-Intervention
This study assessed thirty clients with substance use disorders as participants from the
outpatient treatment program in Jakarta, Indonesia. After sending the proposal and verifying the
research topic with the program manager, screening was conducted based on the comprehensive
assessment. Recruitment started in March and ended in April 2022, and all the assessments were
completed by June 2022. All forty-five eligible clients at the outpatient treatment program
received an invitation to participate in the study. Clients that were interested then filled out the
informed consent before then completed the self-report craving and mindfulness scale as the
baseline assessment via Google Form. After meeting the required number of participants, the
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program was discussed with the director and the addiction counselors to determine the
randomized treatment and control groups. Then, the counseling and mindfulness meditation
schedules were managed by working with the counselors.
The Intervention
All participants received TAU which consisted of programs such as medical and
psychological assessment, substance use education, individual counseling and group counseling.
Participants in the treatment group received TAU and mindfulness meditation through guided
meditation videos in a weekly one-on-one session via Zoom for four weeks. During this study,
online videos from the meditation instructor, Tsamara Fahrana, were utilized. According to her
LinkedIn account, Tsamara Fahrana is a wellness coach, yoga and meditation teacher. She also
had completed her master’s study in neuroscience with an emphasis on the study of mindfulness
meditation in emotional regulation. Participants also received the guided meditation video files
as resources to do the self-practice meditation at home. The duration of participants’ selfpracticed meditation was monitored every week.
Meditation can be practiced in a variety of ways. Some meditative practices require some
religious background and rely heavily on religious messages. However, this study uses a general
mindfulness meditation concept that emphasizes breathing techniques and the awareness of
bodily sensations. To support my role as the principal investigator of this study, I completed the
short Mindfulness-Based Relapse Prevention workshop held in Jakarta in 2018. I used the
knowledge from the workshop to teach the participants about breathing techniques in meditation,
the sit position, and how to be aware of bodily sensations.
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This study was comprised of four weekly telehealth interventions. Mindfulness, the
benefits of mindfulness, and the basic meditation technique were explained in the first week. In
the second week, participants did a meditation that focused on the breathing technique and
emotion release. The participants learned how to activate their five senses: seeing, hearing,
smelling, touching, and tasting through a different guided video from the same instructor. Then,
the participants were asked about their reactions and feelings about the mindfulness session. In
the third week, participants learned how to sense their bodies from head to toe. During the
guided meditation, participants were asked to feel their body reactions, including any pain or
uncomfortable feelings. After meditation, the participants were asked if they experienced any
extremely uncomfortable moments throughout the session and how they felt after the meditation.
Participants were debriefed and instructed to complete the follow-up posttests after completing
the program.
Post-intervention
All participants in the treatment and control group completed the post-tests on the
Mindful Awareness and Attention Scale (MAAS) and the Aggregated Drug Craving Scales
(ADCS). Due to the complexity of the Google Forms, the post-test survey was provided via
printed paper with the help of the counselors at the treatment facility.
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Figure 1
The Research Procedure
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Institutional Review Board Process
This study involved human subjects and may result in minimal risks to individuals who
have substance use disorders. As part of the requirement, I completed the CITI training for
graduate students and received approval from the Institutional Review Board (IRB) at St. Cloud
State University prior to conducting this study (see Appendix D).
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Chapter IV: Results
This study aimed to see if there was any significant reduction in substance use craving of
clients in outpatient treatment programs who received the mindfulness meditation treatment. The
Mindfulness Awareness Attention (MAAS) and Aggregated Drug Craving Scale (ADCS) scores
of clients who received the mindfulness meditation program and clients who did not receive the
mindfulness meditation program were collected. This study involved clients from the outpatient
treatment facility located in Jakarta, Indonesia. Pre- and posttest were compared to see whether
clients in a treatment group demonstrated lower substance use cravings after receiving four
weekly telehealth mindfulness meditation than clients who did not receive the mindfulness
meditation intervention. The IBM SPSS 26 program was utilized to compute the datasets for data
analysis.
Demographic Characteristics of Participants
The demographic data that was collected in this study included age, gender, education
background, occupation, and method of substance usage (Table 2). The total of 30 participants
who were involved in this study were all Indonesians. The demographic list provided below is
based on each characteristic. The gender of the participants in this study included thirteen males
and two females in the treatment group, and fifteen males in the control group. Gender
differences in instrument responses were not addressed as they do not pertain to this study’s
research questions.
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In the treatment group, the number of participants identified as full-time workers was
nine, three as part-time workers, and one as unemployed. While in the control group, eight
participants were identified as full-time workers, one participant as a part-time worker, two
participants worked as drivers, and three participants were unemployed. Based on age range, six
participants in the treatment group and ten in the control group were 17-35 years old. In
comparison, nine participants in the treatment group and five in the control group were identified
as older than 35 and younger than 60. Based on the educational background, most of the
participants of this study had graduated from high school (n=13 for both groups). Two
participants had graduated with associate degrees in the treatment group, and two participants
graduated with bachelor's degrees in the control group. Table 2 also identifies the substance use
for the last thirty days, where most of the participants used the substance one to three times in the
last thirty days (n=15 treatment group; n=14 control group) and one participant used the
substance more than three times.
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Table 2
Sociodemographic Characteristics of the Participants
Characteristic

Gender
Female
Male
Age
17-35
36-60
Occupation
Full-time worker
Part-time worker
Entrepreneur
Driver
Unemployed
Other
Cohabitating
Highest educational level
Highschool
Associate Degree
Bachelor’s degree
Substance Use
Alcohol
Cannabis
Methamphetamine
Poly-substance use
Cannabis and alcohol
Cannabis and Meth
Meth and alcohol
Cannabis, Meth, Alcohol
Cannabis, Heroin, Meth
Pain killer medication
Substance Usage in the past 30
days
One-three times
More than three times
Method of Substance Usage
Oral
Smoking
Injection

Treatment
Group
n
%

Control Group
n

%

2
13

86.67
13.37

15
0

100
0

6
9
26
9
2
2
1
1
0
37

40
60
52
60
13.33
13.33
6.67
6.67
0
74

10
5
26
8
1
0
2
3
1
36

66.67
33.33
52
53.3
6.67
0
13.33
20
6.67
72

13
2
0

86.67
13.33
0

13
0
2

86.67
0
13.33

1
2
6

6.67
13.33
40

0
2
10

0
13.33
66.67

2
1
2
0
0
1

13.33
6.67
13.33
0
0
6.67

0
1
0
0
2
0

0
6.67
0
0
13.33
0

15
0

100
0

14
1

93.33
6.67

2
13
0

13.33
86.67
0

0
14
1

0
93.33
6.67
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Reliability of Measures
The Cronbach's Alpha test was conducted to test the reliability of the two measurements.
The resulting α coefficient of reliability ranges from 0 to 1 in providing this overall assessment
of a measure's reliability, indicating how high or low the items have shared covariance and
probably measure the same concept.
Table 3

Reliability Statistics of the measures

Measures
MAAS pretest
MAAS posttest
ADCS pretest
ADCS posttest

Cronbach's Alpha
.964
.944
.833
.874

N of Items
15
15
5
5

Table three shows the reliability coefficient of the MAAS and the ADCS before and after
the intervention (pretest and posttest). The questionnaire of MAAS consisted of 15 items and
ADCS consisted of five items. The Cronbach’s Alpha scores of the MAAS for both pretest and
posttest were considered excellent (α= .964 for the pretest and α=944 for the posttest). The
Cronbach’s Alpha scores of the ADCS for both pretest and posttest were considered good (α=
.833 for the pretest and α=.874 for the posttest).
Research Question One
To answer research question number one, first, the MAAS score was subjected to a twoway analysis of variance having two levels of groups (treatment group and control group) and
two levels of time (pretest and posttest). All effects were statistically significant at the .05
significance level (see table 4 below)
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Table 4
Descriptive Statistics of the MAAS
Dependent Variable: MAAS
Groups
Treatment Group

Control Group

Total

Times
Pretest
Posttest
Total
Pretest
Posttest
Total
Pretest
Posttest
Total

Mean
73.60
76.20
74.90
74.13
73.26
73.70
73.86
74.73
74.30

Std.
Deviation
16.26
12.71
14.40
9.42
8.42
8.79
13.06
10.69
11.84

N
15
15
30
15
15
30
30
30
60

Table four shows the descriptive statistics of the MAAS. The treatment group obtained a
slightly lower score on the MAAS than the control group on the pretest. Whereas on the posttest,
the treatment group had a higher average score (M=76.2, SD=12.71) than the control group
(M=73.26, SD=8.42). Thus, it indicates that the participants in the treatment group resulted in a
higher average score of MAAS after receiving the TAU plus the additional telehealth
mindfulness meditation.
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Table 5
Tests of Between-Subjects Effects
Dependent Variable: MAAS
Type III
Sum of
Mean
Source
Squares
df
Square
F
Corrected
77.933a
3
25.978
.177
Model
Intercept
331229.40
1 331229.400 2260.76
0
8
Groups
21.600
1
21.600
.147
Times
11.267
1
11.267
.077
Groups *
45.067
1
45.067
.308
Times
Error
8204.667
56
146.512
Total
339512.00
60
0
Corrected
8282.600
59
Total
a. R Squared = .009 (Adjusted R Squared = -.044)
b. Computed using alpha = .05

Partial
Eta
Noncent. Observed
Sig. Squared Parameter Powerb
.911
.009
.532
.081
.000

.976 2260.768

.702
.783
.581

.003
.001
.005

.147
.077
.308

Table five shows the Tests of Between-Subjects Effects to reveal the interaction between
the effects of groups and times and the combination of groups and times on the MAAS average
score. A 2x2 ANOVA with groups (treatment and control group) and test times (pretest and
posttest) as between-subjects factors revealed the main effect of groups, F (1, 56) = .147, p =
.702, ηp2 = .003, and times, F (1, 56) = .077, p = .783, ηp2 = .001 on the average score of the
MAAS. The table five also shows the main effects by the interaction of groups and times on the
average score of the MAAS, F (1, 56) = .308, p = .581, ηp2 = .005.

1.000
.066
.059
.085
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Table 6
Descriptive Statistics of the ADCS
Dependent Variable: ADCS
Groups
Treatment Group

Control Group

Total

Times
Pretest
Posttest
Total
Pretest
Posttest
Total
Pretest
Posttest
Total

Mean
8.33
5.86
7.10
6.60
6.46
6.53
7.46
6.16
6.81

Std.
Deviation
4.43
3.92
4.30
3.04
3.06
3.00
3.83
3.47
3.68

N
15
15
30
15
15
30
30
30
60

Table six shows the descriptive statistics of the ADCS. The treatment group obtained a
higher score of the ADCS (M=8.33, SD=4.43) than the control group (M=6.6, SD= 3.92) on the
pretest. Whereas on the posttest, the treatment group had a lower average score (M=5.86,
SD=3.92) than the control group (M= 6.46, SD= 3.06). Thus, it indicates that the participants in
the treatment group resulted in a lower average score of ADCS after receiving the TAU plus the
additional telehealth mindfulness meditation sessions.
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Table 7
Tests of Between-Subjects Effects
Dependent Variable: ADCS
Type III
Sum of
Mean
Source
Squares
df
Square
F
a
Corrected
50.583
3
16.86
1.255
Model
Intercept
2788.017
1
2788.01 207.50
Groups
4.817
1
4.81
.358
Times
25.350
1
25.35
1.88
Groups *
20.417
1
20.41
1.52
Times
Error
752.400
56
13.43
Total
3591.000
60
Corrected
802.983
59
Total
a. R Squared = .063 (Adjusted R Squared = .013)
b. Computed using alpha = .05

Partial Eta Noncent. Observed
Sig.
Squared Parameter Powerb
.299
.063
3.765
.318
.000
.552
.175
.223

.787
.006
.033
.026

207.508
.358
1.887
1.520

1.000
.091
.271
.228

Table seven shows the Tests of Between-Subjects Effects to compare ADCS average
score differences between participants in two level conditions by groups, treatment and control
group, and by time of intervention, pretest and posttest. A 2x2 ANOVA with groups (treatment
and control group) and times (pretest and posttest) as between-subjects factors revealed the main
effects of groups, F (1, 56) = .358, p = .552, ηp2 = .006, and times, F (1, 56) = 1.88, p = .175, ηp2
= .033 on the average score of the ADCS. Table seven also shows the main effect of the
interaction between groups and times on the average score of the ADCS, F (1, 56) = 1.52, p =
.223, ηp2 = .026.
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Research Question Two
The second research question inquired about the magnitude of the telehealth mindfulness
meditation on the substance use craving. To answer this question, the partial eta squared test was
conducted to find the effect size of the groups and times on the MAAS and ADCS scores. Eta
squared or partial eta squared is a measure of effect size commonly used in ANOVA models. It
measures the variance associated with each main effect and the interaction effect (Tabachnick &
Fidell, 2001). The effect size of the telehealth mindfulness meditation in reducing substance use
craving was considered low (See Tables 5 and 7). The value ηp2 = .006 of the groups effect
indicates that 0.6% of the variance is accounted for by the type of groups, whereas the value
ηp2=.033 of times account for 3.3%, and the value ηp2=.026 of the Groups x Times (G x T)
interaction accounts for 2.6%. Thus, it is considered that the study lacked the power to find
significant effects of telehealth mindfulness meditation in reducing the substance use craving.

40
Chapter V: Conclusion
This study examined the effectiveness of the telehealth mindfulness mediation to reduce
the substance use craving of clients with substance use disorders in the outpatient treatment. A
randomized controlled study design was conducted to find the effectiveness of telehealth
mindfulness meditation as an additional treatment in the outpatient treatment facility in Jakarta,
Indonesia. This study involved 30 participants who were divided into two groups, 15 participants
in the control group and 15 participants in the treatment group. The independent variables of this
study were the two groups (the treatment and the control group) and the two level of test time
(pretest and posttest), while the mindfulness and substance use craving were the dependent
variables. The participants in the control group of this study received the treatment as usual
(TAU) that covers the assessments, eight individual counseling sessions, two group counseling
sessions, random urine analysis, and psychoeducation. At the same time, participants in the
treatment group received the TAU with the four weekly telehealth mindfulness meditation as an
additional program.
To identify the effectiveness of the additional four weekly telehealth mindfulness
meditation, this study conducted a 2-two-way ANOVA to examine the interaction between the
independent variables on the mindfulness and substance use craving as the dependent variables.
The Mindfulness Attention Awareness Scale (MAAS) and the Aggregated Drug Craving Scale
(ADCS) were utilized in this study to measure the dependent variables. The additional of the
telehealth mindfulness meditation treatment concluded as a more effective treatment if the
statistical result showed a significant average score differences of the ADCS and the MAAS
before and after receiving the intervention. The partial eta squared test also was calculated to

41
measure the effect size of both independent variables on the MAAS and ADCS average score
changes.
To answer the first research question, this study compared the average score differences
of the ADCS scores before and after receiving the treatment in both the treatment group and
control group. The comparison of the average score of ADCS between the treatment group and
the control group after completing the intervention was equal. There was no difference in
average at any level of the independent variables (F (1, 56) = .358, p = .552, ηp2 = .006 for any
group comparison and F (1, 56) = 1.88, p = .175, ηp2 = .033 for any time comparison). This
study also found that the effect of one independent variable does not depend on the effect of the
other independent variable, which means no interaction between the treatment and control group
and the pretest and posttest in substance use craving reduction (F (1, 56) = .308, p = .581, ηp2 =
.005). Even though the treatment group had a lower substance use craving level (M= 5.86, SD=
3.92) than the control group (M= 6.46, SD= 3.06) after receiving the treatment. Based on the
findings, it concluded that the additional four weekly telehealth mindfulness meditation
treatment was not proven significantly more effective than the TAU in the clients' substance use
craving reduction. The insignificant differences between the control and treatment groups may
be affected by outlier factors that were not studied in this research.
Furthermore, this study also measures the effect of the independent variables, groups and
times, on the mindfulness level. This study found that the treatment group obtained a higher
MAAS score (M= 76.20, SD=12.71) than the control group (M=73.26, SD=8.42) after receiving
the four weekly telehealth mindfulness meditation sessions. However, there was no significant
difference on the MAAS score of clients who received the TAU only and clients who received
the TAU plus the additional telehealth mindfulness meditation treatment (F (1, 56) = .147, p =
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.702, ηp2 = .003 for between groups variable and F (1, 56) = .077, p = .783, ηp2 = .001 for
between times variables). This result showed that participants who received four weekly
telehealth mindfulness meditation sessions had an equal score to those who did not receive the
four weekly telehealth mindfulness meditation sessions. It concluded that the growth of
mindfulness score before and after receiving the intervention was not statistically affected by the
four weekly telehealth mindfulness meditation sessions. Further, this study also found that the
combination of two independent variables did not significantly affect the MAAS scores (F (1,
56) = .308, p = .581, ηp2 = .005). Thus, the study resulted that the additional four weekly
telehealth mindfulness meditation did not significantly increase the mindfulness level.
On the second research question, this study examined the magnitude of the telehealth
mindfulness meditation on the substance use craving. The partial eta squared was conducted to
estimate the power of the telehealth mindfulness meditation in reducing the substance use
craving on both independent variables. The finding demonstrates that the effect size of telehealth
mindfulness meditation in reducing substance use craving was low for both group variables (ηp2
= .006) and test time (ηp2= .033). It indicates that this study lacks sufficient magnitude to
provide a significant effect on the substance use craving reduction. The results of this study
cannot support the previous study from Bowen & Witkiewitz (2010) that found the practice of
mindfulness meditation is incorporated with a lower risk for substance use relapse.
The implication of this study is to provide various treatment modalities that could help
the success of substance use disorder treatment. Mindfulness as an evidence-based treatment can
be the additional alternative method to increase clients' awareness and emotional regulation
related to how clients manage their substance use cravings, if any. The implementation for future
research, regarding the limited studies of the telehealth method implementation in substance use
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treatment facilities, this study can provide more information about the effectiveness of
telehealth-based treatment that escalated by the COVID-19 pandemic around the world. Future
research also can specify the study to investigate clients and therapy providers' familiarity and
satisfaction with online platforms to reduce the outliers that can affect to the results of the study.
There are some limitations to this study. One of the limitations of this study is the short
period of four weekly interventions of the telehealth mindfulness meditation sessions. Four
sessions of intervention were considered not to be as effective as a more extended period of
intervention in the correlation of substance use craving. Based on a study by Enkema & Bowen
(2017), the number of days per week and the number of minutes per day can significantly
moderate the relationship between craving and the number of substances used in the following
months. This study also does not study the follow-up of substance use craving and mindfulness
level three to six months after the treatment was implemented. Future research can add this
follow-up to examine if the treatment is effective for months after it has concluded. Further, the
number of participants in this study was limited to some categories that cannot be generalized.
For example, only two out of thirty participants were female, and all the participants were
classified as Indonesian. Thus, the results do not apply to identifying whether the culture and
gender of the participants of the program affect the success of online mindfulness meditation in
reducing substance use cravings. This study only applied to clients in the outpatient treatment
facility that only provides adequate treatment for mild to moderate substance use disorders.
Thus, the findings of this study are not relevant to programs that are applied in different settings.
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Appendix A: Mindful Attention Awareness Scale Questionnaire
(In Indonesian Language)

SKALA MINDFULNESS ATTENTION AWARENESS SCALE (MAAS)
Instruksi
Berikut ini kumpulan pernyataan mengenai pengalaman sehari-hari Anda. Beri penilaian seberapa
sering atau jarang Anda mengalami setiap hal, dengan menggunakan skala 1 (hampir selalu) dan
6 (hampir tidak pernah). Jawablah berdasarkan pengalaman Anda yang sesungguhnya, bukan
berdasarkan yang sepantasnya Anda alami. Perlakukan tiap butir pernyataan secara terpisah
dengan butir lain.

1
Hampir
Selalu

2
Sering

3
Agak Sering

4
Agak Jarang

5
Jarang

6
Hampir
Tidak
Pernah

Ketika saya mengalami
emosi tertentu, saya
mengabaikannya selama

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

beberapa waktu.
Karena ceroboh, tidak
waspada, atau karena sibuk
berpikir tentang hal lain, tanpa
sengaja saya merusak barang.
Saya merasa sulit untuk
fokus pada kejadian yang tengah
berlangsung.
Saya berjalan kaki
terlampau cepat tanpa
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menghiraukan hal lain yang saya
lewati di sepanjang perjalanan.
Ketika badan saya terasa
tidak nyaman, saya
mengabaikannya sampai sakitnya

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

menjadi tak tertahankan.
Saya lupa nama orang
segera setelah berkenalan.
Saya berperilaku
otomatis, tanpa memahami apa
yang sedang saya lakukan.
Saya tergesa-gesa dalam
beraktivitas, tanpa
memperhatikan apa yang
sebetulnya tengah saya kerjakan.
Pikiran saya terbawa pada
hasil akhir, sehingga saya
mengabaikan proses yang tengah
saya kerjakan untuk meraihnya.
Saya melakukan
pekerjaan secara otomatis,
mengabaikan apa yang sedang
saya kerjakan.
1
Hampi
r
Selalu

2
Serin
g

3

4

Agak

Agak

5

6

Serin

Jaran

Jarang

Hampir Tidak Pernah

g

g

Ketika orang lain
berbicara, saya hanya menyimak

1

2

3

4

5

6
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karena secara bersamaan saya
sibuk melakukan hal lain.
Saya bepergian tanpa

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

memahami mengapa saya ingin
pergi ke tempat tersebut.
Saya merasa terbebani
dengan masa depan dan masa
lalu.
Saya merasa tidak
sepenuhnya fokus dalam
mengerjakan segala sesuatu
Ketika saya memakan
kudapan (jajanan), saya
melakukannya tanpa sadar.
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Mindful Attention Awareness Scale Questionnaire
(In English)
Instructions: Below is a collection of statements about your everyday experience. Using
the 1-6 scale below, please indicate how frequently or infrequently you currently have each
experience. Please answer according to what really reflects your experience rather than what you
think your experience should be. Please treat each item separately from every other item.
1

2

3

4

5

6

almos

ver

somewh

somewh

ver

almos

t always

y
frequently

at frequently

at infrequently

y

t never

infrequentl
y

_____ 1. I could be experiencing some emotion and not be conscious of it until sometime
later.
_____ 2. I break or spill things because of carelessness, not paying attention, or thinking
of something else.
_____ 3. I find it difficult to stay focused on what’s happening in the present.
_____ 4. I tend to walk quickly to get where I’m going without paying attention to what I
experience along the way.
_____ 5. I tend not to notice feelings of physical tension or discomfort until they really
grab my attention.
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_____ 6. I forget a person’s name almost as soon as I’ve been told it for the first time.
_____ 7. It seems I am “running on automatic,” without much awareness of what I’m
doing.
_____ 8. I rush through activities without being really attentive to them.
_____ 9. I get so focused on the goal I want to achieve that I lose touch with what I’m
doing right now to get there.
_____ 10. I do jobs or tasks automatically, without being aware of what I'm doing.
_____ 11. I find myself listening to someone with one ear, doing something else at the
same time.
_____ 12. I drive places on ‘automatic pilot’ and then wonder why I went there.
_____ 13. I find myself preoccupied with the future or the past.
_____ 14. I find myself doing things without paying attention.
_____ 15. I snack without being aware that I’m eating.
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Appendix B: Aggregated Drug Craving Scale (ADCS)
(In Indonesian Language)
Petunjuk: Lingkarilah nomor yang paling sesuai yang menggambarkan kondisi anda pada
setiap aitem selama satu minggu terakhir.
No

Aitem

Frekuensi/Intensitas/Durasi
0. Tidak pernah (0 kali per minggu)
1. Jarang (1-2 kali seminggu)

Seberapa sering anda
2. Situasi tertentu (3-4 kali per minggu)
berpikir untuk menggunakan
3. Kadang-kadang (5-10 kali per minggu)
narkoba atau memikirkan
4. Sering (11-20 kali per minggu atau 2-3 kali per
1

tentang bagaimana
hari)
menggunakan narkoba akan
5. Sering sekali (21-40 kali per minggu atau 3-6
membuat perasaan anda
kali per hari)
menjadi baik?
6. Hampir setiap saat (lebih dari 40 kali per
minggu atau lebih dari 6 kali per hari)
0. Tidak sama sekali
Pada keadaan yang

1. Sangat Ringan

paling parah, seberapa kuat

2. Ringan

dorongan keinginan anda

3. Sedang

2

untuk menggunakan narkoba? 4. Kuat, tapi dapat dikendalikan
5. Kuat dan sulit dikendalikan
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6. Sangat kuat, dan akan menggunakan narkoba
jika tersedia
Berapa total waktu

3

0. Tidak sama sekali

yang Anda habiskan untuk

1. Kurang dari 20 menit

memikirkan tentang

2. 21 hingga 45 menit

bagaimana menggunakan

3. 46 hingga 90 menit

narkoba berpengaruh pada

4. 90 menit hingga 3 jam

perasaan Anda atau

5. Antara 3 hingga 6 jam

bagaimana menggunakan

6. Lebih dari 6 jam

narkoba membuat perasaan
anda menjadi baik?
0. Tidak sulit sama sekali
1. Hampir tidak sulit sama sekali
Seberapa sulit Anda
2. Agak sulit
menolak untuk menggunakan
4

3. Sedang
narkoba jika narkoba tersedia
4. Sangat sulit
di rumah anda?
5. Sulit yang teramat ekstrim
6. Tidak mampu menahan
Ingatlah jawaban anda

5

0. Tidak pernah memikirkan narkoba dan tidak

pada pertanyaan-pertanyaan

pernah memiliki keinginan untuk

sebelumnya, berilah rata-rata

menggunakan narkoba
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tingkatan keinginan Anda

1. Jarang memikirkan narkoba dan jarang

untuk menggunakan narkoba

memiliki keinginan untuk menggunakan

selama satu minggu terakhir.

narkoba
2. Pada saat tertentu memikirkan narkoba dan
pada saat tertentu memiliki keinginan untuk
menggunakan narkoba
3. Kadang memikirkan narkoba dan kadang
memiliki keinginan untuk menggunakan
narkoba
4. Sering memikirkan narkoba dan sering
memiliki keinginan untuk menggunakan
narkoba
5. Sering sekali memikirkan narkoba dan sering
sekali memiliki keinginan untuk
menggunakan narkoba
6. Hampir selalu memikirkan narkoba dan
hampir selalu memiliki keinginan untuk
menggunakan narkoba
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Aggregated Drug Craving Scale (ADCS)
(In English)
During the past
week…
1. How often did you

0 Never (0 times per week)

think about drinking

1 Rarely (1-2 times per week)

alcohol/using drugs or about

2 Occasionally (3-4 times per week)

how good drinking

3 Sometimes (5-10 times per week)

alcohol/using drugs would

4 Often (11 -20 times per week or 2-3 times per day

make you feel?

5 Most of the time (21-40 times per week or 3-6 times per
day)
6 Nearly all the time (more than 40 times per week or more than
6 times per day)

2. At its most severe

0 None at all

point, how strong was your

1 Slight

craving to drink alcohol/use

2 Mild

drugs?

3 Moderate
4 Strong, but easily controlled
5 Strong and difficult to control
6 Strong urge and would have drunk alcohol or used drugs if
available
3. How much time (in

total) did you spend thinking

0 None at all
1 Less than 20 minutes
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about how drinking

2 21 to 45 minutes

alcohol/using drugs or about

3 46 to 90 minutes

how good drinking

4 90 minutes to 3 hours

alcohol/using drugs would

5 Between 3 to 6 hours

make you feel?

6 More than 6 hours

4. How difficult

0 Not difficult at all

would it have been to resist

1 Very mildly difficult

drinking alcohol/using drugs

2 Mildly difficult

if you had known

3 Moderately difficult

alcohol/drugs were in your

4 Very difficult

house?

5 Extremely difficult
6 Would not be able to resist
5. Keeping in mind

your responses to the
previous questions, please
rate your overall average
alcohol/drug craving for the
past week.

0 Never thought about alcohol/drugs and never had the urge to
drink/use drugs.
1 Rarely thought about alcohol/drugs and rarely had the urge to
drink or use drugs.
2 Occasionally thought about alcohol/drugs and occasionally had
the urge to drink or use drugs.
3 Sometimes thought about alcohol/drugs and sometimes had the
urge to drink or use drugs.
4 Often thought about alcohol/drugs and often thought about
having a drink or use drugs.

62
5 Thought about alcohol/drugs most of the time and had the urge
to drink or use drugs most of the time.
6 Thought about alcohol/drugs nearly all of the time and had the
urge to drink or use drugs nearly all of the time.
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Appendix C: Demographic Questionnaire
3.
4.
5.
6.

Nama Lengkap
Email
Berapa usia Anda saat ini?
Jenis Kelamin
a. Perempuan
b. Laki-laki

7. Status Pekerjaan
a. Bekerja paruh wakt
b. Bekerja full time
c. Tidak bekerj
d. Pelajar
e. Lainnya:
8. Background Pendidikan terakhir
a. Lulus SD
b. Lulus SMP
c. Lulus SMA
d. Lulus Sarjana S1
e. Lulus Sarjana S2 dan/atau S3
f. Lainnya;

9. Histori pemakaian narkoba (boleh pilih lebih dari 1)
a. Ganja
b. Heroin
c. Shabu
d. Benzodizepine atau obat penenang
e. Ecstasy
f. Alcohol
g. LSD
h. Lainnya:
10.
Berapa jumlah rawat inap atau rawat jalan termasuk detoks (treatment narkoba)
yang telah Anda lakukan?
a. 1-3 kali
b. 4-6 kali
c. Belum pernah sama sekali
d. Lebih dari 6 kali
a. Kapan pertama kali Anda pakai narkoba? (contoh: ketika usia 17 tahun)
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b.

a.
b.
c.
d.
e.
f.
a.
b.
c.
d.
e.

Apakah Anda pernah mendengar atau mempelajari tentang teknik mindfulness
sebelumnya?
c. Bagaimana Anda menggunakan / mengkonsumsi zat narkoba?
Hisap melalui mulut
Oral (minum, telan)
Snort (lewat hidung)
Suntik
Di hirup / inhalan
lainnya
d. Berapa jumlah pemakaian narkoba dalam 30 terakhir?
1-3 kali
4-6 kali
7-10 kali
Lebih dari 10 kali
Tidak sama sekali
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Appendix D: Institutional Review Board Approval

